Govt Approves Sinovac Jabs 'in The Public Interest'

"); jQuery("#212 h3").html("

Related News Programmes

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1576185_1_20210218193250.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1576185-20210218.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1576185-20210218.htm', 'DCS.dcsqry', '' ); } } }); }); });

2021-02-18 HKT 12:16

Share this story

facebook

  • The approval of the Sinovac jabs comes just a day before the first doses are expected to arrive. Image: Shutterstock

    The approval of the Sinovac jabs comes just a day before the first doses are expected to arrive. Image: Shutterstock

The government on Thursday approved the use of a Covid-19 vaccine made by mainland firm Sinovac, describing it as a necessary move and one that is in the public interest.

Experts advising the SAR authorities on coronavirus vaccines said earlier this week that with a reported efficacy rate of 62.3 percent, the protection offered by the Sinovac jabs would outweigh any risks.

A million doses of the vaccine are expected to arrive in Hong Kong on Friday, with doctors anticipating that the vaccination programme could be rolled out as soon as next week.

A government statement said the secretary for health considered it necessary to approve the Sinovac jabs after considering the experts' opinion and the public health risks posed by the pandemic.

The statement said the government will complete the necessary quality checks after receiving the jabs, and will continue to ask Sinovac to provide it with the latest clinical data.

The SAR government eventually decided not to require the mainland company to publish clinical data in medical journals before its jabs could be approved here. The vaccine has so far not been approved by the World Health Organisation.

The Sinovac vaccine is the second approved for use in the SAR, after jabs made by German firm BioNTech were earlier given the green light.

RECENT NEWS

Vietnam And South Korea Launch Cross-Border QR Payments

Vietnam and South Korea have launched cross-border QR payments that allow Korean users to pay merchants in Vietnam thro... Read more

WeChat Pay Integrates With Local QR Networks In 5 Asian Countries

WeChat Pay has integrated its service with national QR code networks in five Asian countries, simplifying cross-border ... Read more

Global Transition Finance Ecosystem Gains Momentum

The global transition finance ecosystem is gaining momentum. According to new research by the Hong Kong Institute for M... Read more

Banking Circle Taps PayGate To Ease KRW Cross-Border Payments Into South Korea

Global payments bank Banking Circle will now handle cross-border transactions and settlement flows for South Korean pay... Read more

Equinix AI Discovery Hub Opens In Hong Kong For Enterprise AI

Digital infrastructure company Equinix is partnering with Hewlett Packard Enterprise (HPE) to launch the Equinix AI Dis... Read more

Tencent, Alibaba Eye DeepSeek Stake As AI Startup Tops US$20B Valuation

Chinese tech giants Tencent and Alibaba are in discussions to invest in AI startup DeepSeek, The Information reported, ... Read more